MedPath

pper gastrointestinal endoscopic findings in Japanese with rheumatoid arthritis (RA) receiving long-term NSAIDs therapy, and the usefulness of switching to selective COX-2 inhibitor celecoxib

Not Applicable
Conditions
Rheumatoid arthritis (RA) NSAIDs-induced gastrointestinal mucosal injury
Registration Number
JPRN-UMIN000004271
Lead Sponsor
Hoshigaoka Koseinenkin Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with 1. Gastrectomy or vagotomy 2. Malignancy 3. Severe hepatic dysfunction 4. Severe renal dysfunction 5. Severe cardiac dysfunction 6. hematologic disease 7. Patients showing hypersensitive reaction to celecoxib or one member of the sulfonamide class 8. Patients being pregnant or plan to become pregnant during treatment 9. Patients who are regarded as inadequate subject by physician in charge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath